352 Results

People

  1. Landgren
    Landgren
  2. Levine
    Levine
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Moskowitz
    Moskowitz
  6. Younes
    Younes
  7. Abdel-Wahab
    Abdel-Wahab
  8. Dogan
    Dogan
  9. Horwitz
    Horwitz
  10. Perales
    Perales

Groups

  1. Department of Medicine (294)
  2. Hematologic Malignancies, Division of (292)
  3. Center for Hematologic Malignancies (269)
  4. Adult Leukemia (106)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (43)
  10. Myeloma (41)
  1. "Ferrata Storti Foundation"
Formats
  1. Meeting Abstract (178)
  2. Journal Article (122)
  3. Research Letter (25)
  4. Editorial (15)
  5. Review (10)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (294)
  2. Hematologic Malignancies, Division of (292)
  3. Center for Hematologic Malignancies (269)
  4. Adult Leukemia (106)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Andrew Zelenetz (24)
  3. Martin Tallman (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (12)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (348)
  2. Haematologica Meeting Reports (4)
Publishers
  1. Ferrata Storti Foundation (352)

Results (352)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy
    Journal Article

    Stone, E. F.; Avecilla, S. T.; Wuest, D. L.; Lomas-Francis, C.; Westhoff, C. M.; Diuguid, D. L.; Sadelain, M.; Boulad, F.; Shi, P. A.
    Haematologica (2021)

    Fulltext@MSK | Save
  • Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia
    Research Letter

    Eyre, T. A.; Lamanna, N.; Roeker, L. E.; Ujjani, C. S.; Hill, B. T.; Barr, P. M.; Lansigan, E.; Cheson, B. D.; Yazdy, M.; Allan, J. N.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: Outcomes from a large multi-center collaboration
    Journal Article

    Stephens, D. M.; Boucher, K.; Kander, E.; Parikh, S. A.; Parry, E. M.; Shadman, M.; Pagel, J. M.; Cooperrider, J.; Rhodes, J.; Mato, A.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia
    Journal Article

    Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Vemuri, S.; Flynn, J.; Hsu, M.; Devlin, S. M.; Roshal, M.; Gao, Q.; Shukla, M.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
    Journal Article

    Maura, F.; Dodero, A.; Carniti, C.; Bolli, N.; Magni, M.; Monti, V.; Cabras, A.; Leongamornlert, D.; Abascal, F.; Diamond, B.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Aumento del uso y del coste de recursos sanitarios en pacientes hospitalizados seropositivos para CMV receptores de trasplantes alogénicos de células madre hematopoyéticas bajo tratamiento preventivo
    Meeting Abstract

    Fernandez-Cuesta, I.; Fang, J.; Zavras, P. D.; Su, Y.; Raval, A.; Tang, Y.; Stern, A.; Perales, M. A.; Giralt, S.; Papanicolaou, G.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Somatic mutations are shared between circulating endothelial cells (CEC) and CD34+ hematopoietic stem cells (HSC) in patients with primary myelofibrosis. Can PMF-initiating cells derive from a common HSC/EC precursor?
    Meeting Abstract

    Farina, M.; Bernardi, S.; Polverelli, N.; Zanaglio, C.; D'Adda, M.; Malagola, M.; Re, F.; Cattina, F.; Zollner, T.; Rossi, G.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • Revealing transcriptome deregulation upon genomic complexity in multiple myeloma
    Meeting Abstract

    Ziccheddu, B.; Da Vià, M. C.; Dugo, M.; Lionetti, M.; Todoerti, K.; D'Agostino, M.; Neri, A.; Maura, F.; Corradini, P.; Bolli, N.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Modulation of the immune microenviroment in multiple myeloma patients treated with daratumumab-based therapy: Tumor cell-extrinsic effects of daratumumab treatment
    Meeting Abstract

    Castella, B.; D'Agostino, M.; Giannotta, C.; Oliva, S.; Genuardi, E.; Gilestro, M.; Ruggeri, M.; Corradini, P.; Ziccheddu, B.; Maura, F.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • New option for improving hematological recovery: Suppression of luteinizing hormone
    Editorial

    Elias, H. K.; Van den Brink, M. R. M.
    Haematologica (2020)

    Fulltext@MSK | Save